Genome Valley

India’s pharma growth is increasingly being shaped not just by companies, but by clusters. From Hyderabad Pharma City and Genome…

Anshuman Magazine, Chairman & CEO – India, South-East Asia, Middle East & Africa, CBRE, highlights Hyderabad’s growing…

Gross office leasing space by life sciences firms in India increased by ~56 per cent Y-o-Y to 5.8 mn. sq. ft., the highest-ever in…

New 136,000 sq. ft. research and innovation campus strengthens Hyderabad’s life sciences sector

Vishal Goel, MD, RX Propellant outlines how transitioning from isolated industrial clusters to integrated research campuses can…

The Neovantage Innovation Parks portfolio is set up as a joint venture (JV) between Ivanhoé Cambridge, the real estate group of…

Vishal Goel, MD, RX Propellant

Pushes the accelerator for three-phased Genome Valley: Rx Propellant

This unit will have a BSL3 facility for the manufacture of Drug substances and a Fill-Finish capability for the production of both…

Proposed biopharma manufacturing facility at Genome Valley, Telangana to cater to domestic and export markets including regulated…